SCHEMBL13870632

SCHEMBL13870632

CNC(=O)NCc1ccoc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
FAAH O00519 2/20 0.47
MAPT P10636 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
CNR2 P34972 2/20 0.47
RECQL P46063 1/20 0.47
BLM P54132 1/20 0.47
TSHR P16473 2/20 0.47
OPRK1 P41145 1/20 0.44
HTT P42858 2/20 0.42
USP2 O75604 1/20 0.42
ALOX5 P09917 1/20 0.41
FPR3 P25089 1/20 0.41
FPR2 P25090 1/20 0.41
NAMPT P43490 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 2/20 0.40
NPC1 O15118 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL48739 0.81 KMT2A (0.50) ALDH1A1FAAHMAPTMEN1KMT2A
SCHEMBL12313338 0.79 FAAH (0.57) ALDH1A1FAAHMAPTMEN1KMT2A
SCHEMBL8295045 0.77 ERCC1 (0.53) ALDH1A1FAAHMAPTMEN1KMT2A
SCHEMBL12265799 0.77 HDAC6 (0.51) ALDH1A1FAAHMAPTMEN1KMT2A
SCHEMBL28237509 0.76 FAAH (0.65) ALDH1A1FAAHMAPTMEN1KMT2A
SCHEMBL14868581 0.75 ALDH1A1 (0.39) ALDH1A1FAAHMAPTMEN1KMT2A
SCHEMBL178475 0.74
SCHEMBL28226955 0.73 ALDH1A1 (0.46) ALDH1A1FAAHMAPTMEN1KMT2A
SCHEMBL969258 0.73 SMN1; SMN2 (0.67) ALDH1A1MAPTMEN1KMT2ATSHR
SCHEMBL14075472 0.72 MEN1 (0.52) MEN1KMT2ASMN1; SMN2LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7517995-B2 Thiazolyl-dihydro-cyclopentapyrazole BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-14 US disclosed
US-20070238730-A1 THIAZOLYL-DIHYDRO-CYCLOPENTAPYRAZOLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070238730-A1 THIAZOLYL-DIHYDRO-CYCLOPENTAPYRAZOLE REN, ROR1, RORB ALDH1A1 115/4885FAAH 4328/4885MAPT 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.